DM BIOMED DEVELOPMENT
ActiveSummary
DM BIOMED DEVELOPMENT has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €108k and a net result of €31k. Equity is shrinking by ~5.7% per year across the filed fiscal years. Its solvency ranks better than 84% of 31694 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
97
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability99▼-1
Solvency100=
Growth58=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €10k at 30 days acceptable
Liquidity ample (current ratio 7.21 against 20.71 in 2024; short-term debt: 13.5% and cash: 67.4% of total assets), and 13.5% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
86.5%
Return on assets
24.5%
Age of the figures
12 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €108k
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 24-02-2026, 65 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
65 d early
2024
5 d early
2023
71 d early
2022
25 d early
2021
51 d early
2020
81 d early
2019
77 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€31k▲ 46.2%
2024 · €21k
2018: €12k
2019: €17k
2020: €32k
2021: €36k
2022: €20k
2023: €-12k
2024: €21k
2018 → 2025
Working capital
€104k▲ 35.7%
2024 · €77k
2018: €190k
2019: €62k
2020: €97k
2021: €104k
2022: €65k
2023: €55k
2024: €77k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€107k-€68k▼ 35.9%€56k▼ 17.5%€77k▲ 37.0%€108k▲ 39.5%
Operating result€47k-€30k▼ 36.5%€-10k€27k€44k▲ 64.9%
Net result€36k-€20k▼ 44.8%€-12k€21k€31k▲ 46.2%
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 65% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €125k
Fixed assets
€4k ▲ 773%
Current assets
€121k ▲ 50.0%
Equity and liabilities €125k
Equity
€108k ▲ 39.5%
Debt
€17k ▲ 332%
Debt's share of the balance-sheet total rises from 4.8% to 13.5%. Equity and debt are higher.
Key figures and ratios
EBITDA
€44k▲
2024 · €28k
Cash flow
€31k▲
2024 · €22k
Current ratio
7.21▼
2024 · 20.71
Quick ratio
6.52▼
2024 · 18.68
Debt to equity
0.16▲
2024 · 0.05
ROE
28.3%▲
2024 · 27.0%
ROA
24.5%▼
2024 · 25.7%
Interest coverage
34.84▲
2024 · 18.18
Debt ≤ 1 year
€17k▲
2024 · €4k
Income taxes
€13k▲
2024 · €4k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines
Balance sheet
Code20242025
Assets
Total assets20/58€81k€125k▲
Fixed assets21/28€406€4k▲
Tangible fixed assets22/27€406€4k▲
Furniture and vehicles24€53€963▲
Other tangible fixed assets26€354€3k▲
Current assets29/58€81k€121k▲
Stocks and contracts in progress3€8k€11k▲
Stocks30/36€8k€11k▲
Amounts receivable within one year40/41€16k€23k▲
Trade receivables40€12k€16k▲
Other amounts receivable41€4k€7k▲
Cash at bank and in hand54/58€51k€84k▲
Deferred charges and accrued income490/1€5k€3k▼
Equity and liabilities
Total equity and liabilities10/49€81k€125k▲
Equity10/15€77k€108k▲
Contributions10/11€62k€62k=
Reserves13€15k€46k▲
Distributable reserves133€15k€46k▲
Amounts payable17/49€4k€17k▲
Amounts payable within one year42/48€4k€17k▲
Trade debts44€1k€5k▲
Suppliers440/4€1k€5k▲
Taxes, remuneration and social security45€2k€12k▲
Taxes450/3€2k€12k▲
Other amounts payable47/48€204-
Accrued charges and deferred income492/3-€50
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€887€447▼
Other operating charges640/8€696€710▲
Gross operating margin9900€28k€45k▲
Operating profit (loss)9901€27k€44k▲
Financial income75/76B€130€335▲
Recurring financial income75€130€335▲
Financial charges65/66B€2k€1k▼
Recurring financial charges65€2k€1k▼
Profit (loss) for the period before taxes9903€25k€43k▲
Income taxes67/77€4k€13k▲
Profit (loss) for the period9904€21k€31k▲
Profit (loss) for the period to be appropriated9905€21k€31k▲
Appropriation of the result
Profit (loss) to be appropriated9906€9k€31k▲
Profit (loss) brought forward from the previous period14P€-12k-
Transfer to equity691/2€9k€31k▲
To other reserves6921€9k€31k▲
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-02
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial
Equity above €100kEq €108k ▲39.5%
2 profitable years in a row build equity to €108k.
25-04
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-09
Financial
Back to profitnet €21k
Net result €21k after one loss-making year.
19-02
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-09
Financial
Weakest financial yearnet €-12k
Net result drops to €-12k, the lowest in the series; recovery starts the following year.
30-09
Financial
Liquidity times 7current ratio 14.43
Current ratio from 2.03 to 14.43; short-term debt falls from €63k to €4k.
05-04
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
10-03
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-09
Financial
Highest result since 2018net €36k ▲10.3%
Operating result €47k, net result €36k, both a record.
08-02
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-09
Financial
Liquidity triplescurrent ratio 12.96
Current ratio from 3.86 to 12.96; short-term debt falls from €22k to €8k.
Show earlier events
30-09
Financial
Equity above €100kEq €101k ▲46.9%
3 profitable years in a row build equity to €101k.
13-02
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
21-02
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
09-02
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
02-03
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sprimont · 1 establishment unit since 2012
Ground area
3,077 m²
Building footprint
107 m²
Volume, LiDAR
638 m³
Parcel 62067F0093/00M000, Wallonia · tallest building 7.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DM Biomed Development
since 20122.206.672.893
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62067F0093/00M000 | Wallonia | 3,077 m² | 1 · 107 m² | 7.3 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CAMAREM
BE 0775.440.269
Overijse · Eq €107,784
PYNK
BE 1010.075.648
Ottignies-Louvain-la-Neuve · Eq €107,770
Sémaj
BE 0776.790.252
Evergem · Eq €107,770
MILLENIUM BUSINESS CONSULT
BE 0466.493.388
Lasne · Eq €107,768
RD SERVICES
BE 0406.340.819
Anzegem · Eq €107,789
Of 82,553 companies in sector 70200 we hold annual accounts for 52,572. 40,704 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded12-01-2012
Fiscal year end30-09
Activities, NACEBEL 2025
70200Business and other management consultancy
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.